Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Møller-Bisgaard

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|July 15, 2024
Spinal Lesions in Axial Psoriatic Disease: How Should They Be Identified and Quantified by Magnetic Resonance Imaging?Mikkel Østergaard, Signe Møller-Bisgaard, Walter P Maksymowych
Trials|April 22, 2015
Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Bo Jannik Ejbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritisMikkel Østergaard, Robert Gw Lambert, Anna Ef Hadsbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee regionMikkel Østergaard, Marie Wetterslev, Anna Ef Hadsbjerg, et al.
Annals of the Rheumatic Diseases|June 15, 2017
Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trialsDaniel Glinatsi, Joshua F Baker, Merete L Hetland, et al.
RMD Open|March 15, 2024
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, et al.
Rheumatology (Oxford, England)|September 15, 2020
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remissionSigne Møller-Bisgaard, Stylianos Georgiadis, Kim Hørslev-Petersen, et al.
JAMA|February 6, 2019
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical TrialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Bo Ejbjerg, et al.
EULAR Rheumatology Open|June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patientsZohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
RMD Open|May 7, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritisZohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|July 15, 2024
Spinal Lesions in Axial Psoriatic Disease: How Should They Be Identified and Quantified by Magnetic Resonance Imaging?Mikkel Østergaard, Signe Møller-Bisgaard, Walter P Maksymowych
Trials|April 22, 2015
Impact of a magnetic resonance imaging-guided treat-to-target strategy on disease activity and progression in patients with rheumatoid arthritis (the IMAGINE-RA trial): study protocol for a randomized controlled trialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Bo Jannik Ejbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritisMikkel Østergaard, Robert Gw Lambert, Anna Ef Hadsbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee regionMikkel Østergaard, Marie Wetterslev, Anna Ef Hadsbjerg, et al.
Annals of the Rheumatic Diseases|June 15, 2017
Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trialsDaniel Glinatsi, Joshua F Baker, Merete L Hetland, et al.
RMD Open|March 15, 2024
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Lykke Midtbøll Ørnbjerg, et al.
Rheumatology (Oxford, England)|September 15, 2020
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remissionSigne Møller-Bisgaard, Stylianos Georgiadis, Kim Hørslev-Petersen, et al.
JAMA|February 6, 2019
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical TrialSigne Møller-Bisgaard, Kim Hørslev-Petersen, Bo Ejbjerg, et al.
EULAR Rheumatology Open|June 29, 2026
The impact of smoking and obesity on secukinumab effectiveness in psoriatic arthritis: real-world evidence from 1202 European patientsZohra Faizy Ahmadzay, Stylianos Georgiadis, Mikkel Østergaard, et al.
RMD Open|May 7, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritisZohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, et al.
Pageof 2